Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angioedema].

H F Merk1

  • 1Universitäts-Hautklinik, RWTH Aachen, Pauwelsstrasse 30, 52074, Aachen, Germany. hans.merk@post.rwth-aachen.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|November 16, 2007
PubMed
Summary
This summary is machine-generated.

Angioedema, a potentially hazardous symptom, can stem from allergic reactions or NSAID hypersensitivity. New therapies like icatibant target bradykinin pathways for specific angioedema types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aryl hydrocarbon receptor signalling in the skin and adverse vemurafenib effects.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Cutaneous side effects of targeted therapies].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Lichenoid drug reactions].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

[Porphyria cutanea tara].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Area of Science:

  • Immunology
  • Pharmacology

Context:

  • Angioedema is a critical symptom of anaphylaxis, sometimes more dangerous than circulatory collapse.
  • It can arise from IgE-mediated allergies, NSAID hypersensitivity affecting arachidonic acid metabolism, or bradykinin dysregulation.
  • Bradykinin-mediated angioedema, including hereditary (HANE) and acquired (EANE) forms, and that induced by ACE inhibitors, presents distinct mechanisms.

Purpose:

  • To explore the mechanisms of angioedema, differentiating allergic and bradykinin-mediated pathways.
  • To review novel therapeutic strategies targeting bradykinin pathways for angioedema treatment.

Summary:

  • Angioedema can be linked to allergic reactions or NSAID hypersensitivity.
  • Bradykinin plays a key role in angioedema when urticaria is absent, as seen in HANE, EANE, and ACE inhibitor-induced cases.

Related Experiment Videos

  • Icatibant, a bradykinin-receptor-2 antagonist, effectively treats HANE by blocking bradykinin's effects.

    • Impact:

    • Highlights the distinct pathophysiology of different angioedema types.
    • Introduces targeted therapies like icatibant for bradykinin-mediated angioedema.
    • Suggests potential for icatibant in ACE inhibitor-induced angioedema, pending further investigation.